Optimal timing ID'd for flu shot during three-week chemo cycle

December 28, 2016

(HealthDay)—For adults with solid cancer undergoing three-week cytotoxic chemotherapy cycles, antibody responses are comparable for influenza vaccination on day one and 11, according to a study published online Dec. 20 in Cancer.

Bhumsuk Keam, M.D., Ph.D., from Seoul National University College of Medicine in South Korea, and colleagues randomized adult with solid cancer undergoing scheduled three-week cytotoxic chemotherapy to receive the 2014 to 2015 seasonal influenza vaccine on day one (43 patients) or 11 (54 patients) during the chemotherapy cycle. Patients were stratified by age and previous influenza vaccination status. The final analysis included 83 patients.

The researchers found that the rates of seroprotection after vaccination were not significantly different for the day one versus day 11 groups (strain H1N1, 67 versus 75 percent [P = 0.403]; strain H3N2, 77 versus 80 percent [P = 0.772]; and strain B, 21 versus 27 percent [P = 0.472]). The groups also had similar seroconversion rates and post-vaccination geometric mean titers. The day 11 group more often had vaccine-related adverse events (32 versus 13 percent; P = 0.040).

"The antibody responses to on days one and 11 during a three-week cytotoxic chemotherapy cycle were comparable," the authors write. "Influenza vaccination can be performed concurrently with cytotoxic chemotherapy or during the cytopenic period."

Explore further: High-dose flu vaccine better protects HIV-infected adults

More information: Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Related Stories

High-dose flu vaccine better protects HIV-infected adults

January 4, 2013

(HealthDay)—HIV-infected adults achieve higher rates of seroprotection when immunized with a high-dose of the influenza trivalent vaccine compared to the standard dose, according to a study published in the Jan. 1 issue ...

CDC: 2012-2013 flu vaccine not as effective in elderly

February 25, 2013

(HealthDay)—Vaccination against influenza for the 2012/2013 flu season appears to be moderately effective in reducing the need for outpatient medical attention, but the effect is lower in the elderly, according to research ...

Recommended for you

Ancient stress response provides clues to cancer resistance

April 25, 2017

Cancer is often able to craftily outwit the best techniques modern medicine has developed to treat it. In an attempt to understand and combat cancer's vaunted prowess, an unusual collaboration between physicists and a leading ...

Studying a catalyst for blood cancers

April 25, 2017

Imagine this scenario on a highway: A driver starts to make a sudden lane change but realizes his mistake and quickly veers back, too late. Other motorists have already reacted and, in some cases, collide. Meanwhile, the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.